Brivudine
- Catalog NO.:A849946
- CAS No. : 69304-47-8
- Molecular Formula:C11H13BrN2O5
- Molecular Weight: 333.14
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
CAS Number | 69304-47-8 | Appearance | White powder |
Catalog Number | A849946 | MDL Number | MFCD00058585 |
Molecular Formula | C11H13BrN2O5 | Molecular Weight | 333.14 |
Boiling Point | 382.9°C at 760 mmHg | Melting Point | |
Flash Point | Density | ||
Synonyms | (E)-5-(2-Bromovinyl)-2'-deoxyuridine | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | H302-H315-H319 | Class | |
Precautionary Statements | P261-P305+P351+P338 | Packing Group |
Description
Brivudine, also known as bromovinyl-deoxyuridine, is a uridine derivative and nucleoside analog with pro-apoptotic and chemosensitizing properties. In vitro, bromovinyl-deoxyuridine (BVDU) has been shown to downregulate the multifunctional DNA repair enzyme APEX nuclease 1, resulting in the inhibition of DNA repair and the induction of apoptosis. In addition, this agent may inhibit the expression of STAT3 (signal transducer and activator of transcription 3), which may result in the downregulation of vascular endothelial growth factor (VEGF). BVDU has also been found to inhibit the upregulation of chemoresistance genes (Mdr1 and DHFR) during chemotherapy. Overall, the gene expression changes associated with BVDU treatment result in the decrease or prevention of chemoresistance. In addition, this agent has been shown to enhance the cytolytic activity of NK-92 natural killer cells towards a pancreatic cancer cell line in vitro. |